Skip to content

Drugs reaction of chemotherapy in breast cancer patients in sms hospital, Jaipur

An Observational Study of Prescription Pattern and Adverse Drug Reaction in Breast Cancer Patients at SMS Hospital, Jaipur.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052551
Enrollment
100
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

omprakash choudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients admitted to the hospital for chemotherapy diagnosed with breast cancer aged between 18 to 60 years. 2. Patients diagnosed with breast cancer who have gone underwent at least one cycle of chemotherapy. 3. Patients diagnosed with breast cancer with a breast carcinoma staging up to stage III.

Exclusion criteria

Exclusion criteria: 1. Out-door patients with a diagnosis of breast cancer. 2. Pregnant and lactating women with a diagnosis of breast cancer. 3. Patients who will not give informed consent for participation in the study.

Design outcomes

Primary

MeasureTime frame
1. To assess the prescription pattern of indoor breast cancer patients receiving chemotherapy treatment in medical oncology department of SMS Hospital. 2. To describe the pattern of Adverse Drugs Reactions in the enrolled patients and to perform causality assessment as per WHO-UMC scale. 3. To identify and describe the potential drug-drug interaction in the enrolled patients using medscape mobile interaction checker. 4. To estimate the proportion of cases where drugs were prescribe according to standard treatment guidelines.Timepoint: Within 1 year

Secondary

MeasureTime frame
1. To assess sociodemographic and clinical profile of patients under study. 2. To describe the different types of breast cancer. 3. To sensitize the health care professional, care givers and patients to report adverse drug reactions to the treatment.Timepoint: Within 1 year

Countries

India

Contacts

Public Contactomprakash choudhary

SMS MEDICAL COLLEG, JAIPUR

monicajain07@yahoo.com9828786533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026